Pfizer agrees to buy Seagen for USD 43 bn
Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering class of targeted cancer drugs, The Wall Street Journal reported.
Source: parisguardian.com
📰 Eagen Which News
Eagen Which News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eagen Which. Real-time updates on events, politics, business and more.